ArticleFrontiers in immunology2025

Multi-omics integration and machine learning identify NPC2 as a prognostic and treatment-responsive regulator in lung adenocarcinoma.

Ang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.